Podcasts

Medtech Matters: AI-Enabled Cardiac Diagnostics

Medtech Matters: AI-Enabled Cardiac Diagnostics

MPO's Sean Fenske speaks with Cardiologs’ Mark Toland and Rick Anderson about the rapidly evolving technology to help address cardiovascular disease.

By Sean Fenske, Editor-in-Chief11.18.20
In this episode of Medtech Matters, a podcast focused on the medical device manufacturing industry and the factors impacting it, we speak with Mark Toland, who was previously the CEO of Corindus, and Rick Anderson, who was formerly the WorldWide Franchise Chairman at J&J. They are now both on the board at Cardiologs. They talk about what interested them in the company, the important role cardiovascular diagnostics play in the battle against heart disease, and the impact of artificial intelligence on the device performance. Specifically, we pose the following questions to him.  
 
  • What is Cardiologs and what attracted you to the organization?
  • What does this influx of AI-powered technologies mean for healthcare?
  • Are the challenges associated with reimbursement when it comes to AI-based technologies being addressed?
  • What challenges are still inhibiting the growth of this technology segment?
  • What is the response from caregivers and physicians? Are they ready to adopt AI-based technologies?
 
Listen to this episode and see what you think of Cardiologs. If you’d like to share thoughts, ask questions, or suggest a future participant for Medtech Matters, please reach out to me at sfenske@rodmanmedia.com.
 
Listen to the podcast streaming via the player or get the podcast on the Medtech Matters channel via your preferred vendor of podcasts, such as Apple Podcasts (iTunes) or Spotify.
 
Click here to review other podcasts.
Related Searches: